Relative Strength (RS) Rating
Search documents
TJX Stock Keeps Getting Stronger; Earns Price Performance Rating Upgrade. Still Shy Of Key Benchmark
Investors· 2025-10-13 21:52
Group 1 - TJX Cos. experienced an improvement in its Relative Strength (RS) Rating, rising from 68 to 75, indicating a positive trend in stock performance [1] - The stock reached a record high in August and is currently trading close to that high, raising questions about its potential to achieve a new all-time high [1] - The overall stock market showed volatility influenced by news from China and comments from Fed chief Powell, with Walmart entering a buy zone [1][2] Group 2 - TJX Cos. received a rating upgrade to 74, reflecting strong earnings performance despite facing higher tariff costs [4] - The company raised its guidance, indicating confidence in future performance despite challenges [4] - Other companies like Snowflake and Palo Alto also showed positive movements ahead of their quarterly results, suggesting a broader trend in the tech and retail sectors [4]
McKesson Stock Shoots To Record High. Health Products Giant Shows Improved Price Strength
Investors· 2025-09-24 18:04
Company Performance - McKesson's stock reached a record high of $748.75 after breaking out of a flat base, continuing to rise to approximately $761 [1][3] - The company reported a 5% earnings gain to $8.26 per share and a 23% increase in revenue to $97.8 billion last quarter [1] - Analyst consensus predicts continued double-digit revenue growth for the remainder of the year [1] Relative Strength Ratings - McKesson's Relative Strength (RS) Rating improved from 66 to 79, nearing the 80 RS Rating threshold that indicates strong market performance [2] - The company holds a B+ Accumulation/Distribution Rating and a 91 EPS Rating out of 99, with a Composite Rating of 78 [2] Industry Position - McKesson ranks No. 2 in the Medical-Wholesale Drugs industry group, with Cencora as the top-ranked stock [4] - The medical wholesale drugs group ranks 166 out of 197 industry groups according to IBD [4]
Oric Pharmaceuticals Stock Scores RS Rating Upgrade
Investors· 2025-09-17 17:45
Group 1 - Oric Pharmaceuticals (ORIC) stock had its Relative Strength (RS) Rating upgraded from 80 to 83, indicating improved performance compared to other stocks over the past 52 weeks [1] - Dianthus Therapeutics stock saw a significant increase of 47% in four weeks and received an RS Rating upgrade [4] - Google stock reached a record high and was included in top stock lists, highlighting its strong market performance [4] Group 2 - PTC Therapeutics stock's RS Rating improved to 77, reflecting a positive trend in its stock performance [4] - Stocks to watch include Oric Pharmaceuticals, which saw its RS Rating jump to 82, indicating strong market interest [4] - The market experienced a sour note at the end of August, with companies like Expedia, DR Horton, and Argenx being in focus for investors [4]
Bitdeer Technologies Group Stock Earns 91 RS Rating
Investors· 2025-09-15 18:10
Group 1 - Bitdeer Technology Group (BTDR) stock received a positive adjustment to its Relative Strength (RS) Rating, increasing from 84 to 91, indicating improved market leadership [1] - Galaxy Digital's RS Rating has also improved, entering the 80-plus level, reflecting a positive trend in its stock performance [2] - Iren stock has achieved a Composite Rating of 96, indicating strong market performance, driven by updates in Bitcoin mining and AI cloud services [4] Group 2 - Bitdeer Technology's RS Rating has shown improvement, now at 83, suggesting a strengthening position in the market [4] - The performance of Bitcoin miners, particularly Iren, has been positively influenced by recent earnings reports and developments related to Nvidia [4] - The overall market for Bitcoin mining stocks appears to be experiencing rallies, supported by advancements in AI technology [4]
Guidewire Stock Soars 20%, Reaches An All-Time High On Exceptional Earnings; Clears Technical Benchmark, Hitting 80-Plus RS Rating
Investors· 2025-09-08 20:09
Core Insights - Guidewire Software (GWRE) experienced a significant stock increase of 20.15% following a quarterly earnings report that exceeded market expectations by 32% [1][3] - The stock's Relative Strength (RS) Rating improved dramatically from 62 to 88, placing it in the top 12% of all stocks for price performance over the past year [2][3] - Guidewire reported a 35% increase in fiscal fourth quarter earnings, reaching 84 cents per share, alongside a 22% revenue growth to $356.6 million [3][4] Financial Performance - The company's earnings per share (EPS) growth of 35% was a decline from a previous quarter's 238% increase, indicating a strong but fluctuating performance [3] - Revenue for the quarter rose by 22%, consistent with the previous quarter's growth rate [3] - Analyst consensus predicts continued earnings growth for the next two quarters, suggesting a positive outlook for the company [5] Stock Performance - Guidewire's stock has increased approximately 140% over the past year and a half, closing just below 262 on Monday [6] - The stock appears to be forming a cup pattern, indicating potential for further growth [6] - Guidewire holds the No. 2 rank in the Computer Software-Financial industry group, with Pagaya Technologies being the top-ranked stock [7] Ratings and Investor Sentiment - The company has a Composite Rating of 93 and an A SMR Rating, indicating strong sales, profit margins, and return on equity [4] - Institutional investors show strong interest in Guidewire, as reflected in its A- Accumulation/Distribution Rating [4] - The EPS Rating is currently at 76, with expectations for improvement based on strong profit growth anticipated this year [5]